Radio-sensitization of human leukaemic molt-4 cells by DNA-dependent protein kinase inhibitor, NU7026

Acta Medica (Hradec Kralove). 2012;55(2):66-73. doi: 10.14712/18059694.2015.57.

Abstract

In this paper we describe the influence of NU7026, a specific inhibitor of DNA-dependent protein kinase, phosphoinositide 3-kinase, and ATM-kinase on molecular and cellular mechanisms triggered by ionising irradiation in human T-lymphocyte leukaemic MOLT-4 cells. We studied the effect of this inhibitor (10 1microM) combined with gamma-radiation (1 Gy) leading to DNA damage response and induction of apoptosis. We used methods for apoptosis assessment (cell viability count and flow-cytometric analysis) and cell cycle analysis (DNA content measurement) and we detected expression and post-translational modifications (Western blotting) of proteins involved in DNA repair signalling pathways. Pre-treatment with NU7026 resulted into decreased activation of checkpoint kinase-2 (Thr68), p53 (Ser15 and Ser392), and histone H2A.X (Ser139) 2 hours after irradiation. Subsequently, combination of radiation and inhibitor led to decreased amount of cells in G2-phase arrest and into increased apoptosis after 72 hours. Our results indicate that in leukaemic cells the pre-incubation with inhibitor NU7026 followed by low doses of ionising radiation results in radio-sensitising of MOLT-4 cells via diminished DNA repair and delayed but pronounced apoptosis. This novel approach might offer new strategies in combined treatment of leukaemia diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / radiation effects
  • Cell Cycle / radiation effects
  • Cell Line, Tumor / radiation effects
  • Cell Proliferation / radiation effects
  • Chromones / pharmacology*
  • DNA Damage / radiation effects
  • DNA Repair / radiation effects
  • DNA-Activated Protein Kinase / antagonists & inhibitors*
  • Gamma Rays
  • Humans
  • Leukemia, T-Cell / radiotherapy*
  • Morpholines / pharmacology*
  • Radiation Tolerance / drug effects*
  • Radiation-Sensitizing Agents / pharmacology*

Substances

  • 2-(morpholin-4-yl)benzo(h)chromen-4-one
  • Chromones
  • Morpholines
  • Radiation-Sensitizing Agents
  • DNA-Activated Protein Kinase